Quick Takeaways
- This page summarizes Robert Kramer's Form 4 filing for Emergent BioSolutions Inc. (EBS).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 02 Mar 2023, 13:42.
Robert Kramer - 28 Feb 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)
- Signature
- /s/ Jennifer Lynn Fox, Attorney-in-fact
- Issuer symbol
- EBS
- Transactions as of
- 28 Feb 2023
- Net transactions value
- -$39,938
- Form type
- 4
- Filing time
- 02 Mar 2023, 13:42:04 UTC
- Previous filing
- 27 Feb 2023
- Next filing
- 06 Mar 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Robert Kramer filed Form 4 for Emergent BioSolutions Inc. (EBS) on 02 Mar 2023."
What Changed
- Previous filing in this sequence was filed on 27 Feb 2023.
- Current net transaction value: -$39,938.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
EBS
transaction
Common Stock
Tax liability
- Transaction value
- $39,938
- Shares
- -3,226
- Change %
- -3%
- Price
- $12.38
- Shares after
- 103,298
- Date
- 28 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents shares of common stock withheld to pay taxes. |